This book investigates the current and future trends in laboratory tests for the early detection, evaluation, and prediction of human tumors. High-profile laboratory scientists and basic cancer researchers review recent and emerging clinical laboratory tests, emphasizing molecular and genetic RNA/DNA tests that can detect individuals at high risk for specific cancers. The authors explore novel serological assays, cellular assays for anatomic pathology, and molecular and genetic assays. Key highlights include genetic tests for colon, lung, and pancreatic cancers, and a discussion of molecular microsatellite instability in cancer diagnosis.

The book is presented as a collection of reviews by leading scientists in the field, aiming to inform therapeutic decisions through advanced diagnostic methods. The content focuses on the critical role of molecular and genetic testing in identifying cancer risks and aiding in diagnosis. The authority perspective suggests a text geared towards medical professionals and researchers seeking to understand the cutting edge of cancer diagnostics.